Loading clinical trials...
Loading clinical trials...
Seroprevalence of Antibodies to Measles, Mumps, and Rubella, and Serologic Responses After Vaccination Among Human Immunodeficiency Virus (HIV)-1 Infected Adults in Northern Thailand
Conditions
Interventions
0.5 ml of MMR vaccine
Locations
1
Thailand
Maharaj Nakorn Chiang Mai Hospital, Department of Medicine, Chiang Mai University
Muang, Chiang Mai, Thailand
Start Date
July 1, 2011
Primary Completion Date
September 1, 2013
Completion Date
March 1, 2014
Last Updated
April 1, 2016
NCT01875588
NCT04929028
NCT07071623
NCT07199335
NCT03087253
NCT05419024
Lead Sponsor
Chiang Mai University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions